0
0
1/6/23 at 2:42pm
Organization
Ophthalmologytimes.com
Author
David Hutton
34 words
0
Comments
The delivery of VivaVision's molecules via the suprachoroidal space using Everads' technology is expected to lead to novel treatments for retinal diseases.
You are the first to view
https://www.ophthalmologytimes.com/view/vivavision-everads-collaborate-to-develop-therapies-for-retinal-diseases
Create an account
or login to join the discussion